Skip to content

A study to learn about the study medicine called PF-08046032 in people with advanced cancers.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517756-35-00
Acronym
C5911001 - SGN-CD25V
Enrollment
33
Registered
2025-04-21
Start date
2025-05-28
Completion date
Unknown
Last updated
2025-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced lymphomas (classic Hodgkin lymphoma [cHL], and diffuse large B cell lymphoma [DLBCL]), and melanoma), HNSCC, NSCLC, peripheral T cell lymphoma [PTCL], Solid tumors (eg

Interventions

None listed

Sponsors

Pfizer Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026